A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Illumina, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 65,561 shares of ILMN stock, worth $9.45 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
65,561
Previous 76,016 13.75%
Holding current value
$9.45 Million
Previous $7.94 Million 7.75%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$105.28 - $135.9 $1.1 Million - $1.42 Million
-10,455 Reduced 13.75%
65,561 $8.55 Million
Q2 2024

Jul 29, 2024

SELL
$101.05 - $133.57 $11.1 Million - $14.7 Million
-110,032 Reduced 59.14%
76,016 $7.94 Million
Q1 2024

May 08, 2024

SELL
$127.73 - $147.2 $30.8 Million - $35.5 Million
-241,027 Reduced 56.44%
186,048 $25.5 Million
Q4 2023

Feb 09, 2024

BUY
$92.79 - $142.53 $853,575 - $1.31 Million
9,199 Added 2.2%
427,075 $59.5 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $38.3 Million - $57.2 Million
296,990 Added 245.68%
417,876 $57.4 Million
Q2 2023

Aug 08, 2023

BUY
$183.43 - $232.67 $874,777 - $1.11 Million
4,769 Added 4.11%
120,886 $22.7 Million
Q1 2023

May 08, 2023

BUY
$193.75 - $232.55 $3.37 Million - $4.04 Million
17,383 Added 17.61%
116,117 $27 Million
Q4 2022

Feb 09, 2023

SELL
$187.24 - $242.74 $10.3 Million - $13.4 Million
-55,266 Reduced 35.89%
98,734 $20 Million
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $1.98 Million - $2.54 Million
-11,173 Reduced 6.76%
154,000 $29.4 Million
Q2 2022

Aug 04, 2022

BUY
$181.58 - $368.0 $7.58 Million - $15.4 Million
41,746 Added 33.82%
165,173 $30.5 Million
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $13.2 Million - $18.5 Million
43,579 Added 54.58%
123,427 $43.1 Million
Q4 2021

Feb 09, 2022

BUY
$347.28 - $421.83 $3.18 Million - $3.86 Million
9,144 Added 12.93%
79,848 $30.4 Million
Q3 2021

Nov 08, 2021

SELL
$405.61 - $524.84 $1.1 Million - $1.42 Million
-2,704 Reduced 3.68%
70,704 $28.7 Million
Q2 2021

Aug 05, 2021

BUY
$372.84 - $481.5 $24.7 Million - $32 Million
66,381 Added 944.66%
73,408 $34.7 Million
Q1 2021

May 05, 2021

SELL
$361.28 - $504.76 $56,359 - $78,742
-156 Reduced 2.17%
7,027 $2.7 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $81,956 - $103,868
280 Added 4.06%
7,183 $2.66 Million
Q3 2020

Nov 09, 2020

SELL
$268.51 - $400.74 $8.18 Million - $12.2 Million
-30,453 Reduced 81.52%
6,903 $2.13 Million
Q2 2020

Aug 04, 2020

BUY
$256.46 - $373.01 $379,304 - $551,681
1,479 Added 4.12%
37,356 $13.8 Million
Q1 2020

May 12, 2020

SELL
$209.2 - $335.53 $143,720 - $230,509
-687 Reduced 1.88%
35,877 $9.8 Million
Q4 2019

Feb 11, 2020

BUY
$288.29 - $335.49 $648,652 - $754,852
2,250 Added 6.56%
36,564 $12.1 Million
Q3 2019

Nov 12, 2019

SELL
$266.84 - $378.23 $11.7 Million - $16.6 Million
-43,778 Reduced 56.06%
34,314 $10.4 Million
Q2 2019

Aug 02, 2019

SELL
$300.59 - $368.15 $1.74 Million - $2.13 Million
-5,779 Reduced 6.89%
78,092 $28.8 Million
Q1 2019

Apr 26, 2019

BUY
$272.57 - $321.18 $8.44 Million - $9.95 Million
30,979 Added 58.57%
83,871 $26.1 Million
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $5.11 Million - $6.88 Million
18,768 Added 55.0%
52,892 $15.8 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $5.64 Million - $7.42 Million
20,207 Added 145.2%
34,124 $12.5 Million
Q2 2018

Aug 01, 2018

BUY
$228.17 - $292.07 $2.38 Million - $3.05 Million
10,445 Added 300.84%
13,917 $3.89 Million
Q1 2018

May 07, 2018

BUY
$209.54 - $253.91 $101,207 - $122,638
483 Added 16.16%
3,472 $821,000
Q4 2017

Feb 01, 2018

SELL
$202.23 - $230.03 $72,600 - $82,580
-359 Reduced 10.72%
2,989 $653,000
Q3 2017

Nov 02, 2017

BUY
$172.3 - $213.93 $576,860 - $716,237
3,348
3,348 $667,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.